China Traditional Chinese Medicine Holdings Co stock analysis
China Traditional Chinese Medicine Holdings Co (WSG) Stock Price & Analysis
WSG Stock Chart & Stats
- Day’s Range
- EUR 0.01 - EUR 0.01
- 52-Week Range
- EUR 0.01 - EUR 0.26
- Previous Close
- EUR 0.14
- Volume
- N/A
- Average Volume (3M)
- 168
- Market Cap
- EUR 686.56M
- Enterprise Value
- EUR 5.96B
- Total Cash (Recent Filing)
- EUR 4.56B
- Total Debt (Recent Filing)
- EUR 1.34B
- Price to Earnings (P/E)
- ―
- Beta
- 3.36
- Next Earnings
- Mar 19, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 4.15%
Bulls Say, Bears Say
Bulls Say
Low Leverage And Financial Flexibility
Falling debt relative to equity gives the company greater financial flexibility over the next several quarters. Lower leverage reduces refinancing pressure and leaves more capacity to support operations, manage industry volatility, or fund selective investment without relying heavily on additional borrowing.
Recent Positive Operating Cash Flow
Positive operating and free cash flow indicates that the business has recently converted its operations into cash even while reported earnings weakened. If maintained, this supports liquidity, internal funding of the TCM business, and resilience against the impact of near-term profitability pressure.
Healthy Gross Profit Generation
Healthy gross profit shows that the core products retain economic value before operating costs and other items are considered. This provides a base for recovery if management can control expenses and other below-gross-profit charges, although the benefit depends on restoring stronger overall profitability.
Bears Say
Profitability Deterioration And 2025 Loss
The shift from sustained profits to a 2025 net loss is a material deterioration in earnings quality and reduces the company’s ability to compound shareholder value. Continued losses could constrain reinvestment and weaken the effectiveness of its otherwise conservative balance sheet.
Revenue Momentum Remains Unstable
Repeated revenue declines indicate that demand or pricing momentum has not been consistently durable across the recent period. Continued contraction could reduce operating leverage, make fixed costs harder to absorb, and limit the likelihood of a sustained recovery in earnings over coming quarters.
Cash-flow Durability Is Uncertain
Although recent cash generation is positive, the longer record includes negative free cash flow and a sharp 2025 growth slowdown. This volatility suggests that cash conversion may depend partly on working-capital movements, making liquidity strength less dependable if operating performance remains weak.
China Traditional Chinese Medicine Holdings Co News
WSG FAQ
What was China Traditional Chinese Medicine Holdings Co’s price range in the past 12 months?
What is China Traditional Chinese Medicine Holdings Co’s market cap?
When is China Traditional Chinese Medicine Holdings Co’s upcoming earnings report date?
How were China Traditional Chinese Medicine Holdings Co’s earnings last quarter?
Is China Traditional Chinese Medicine Holdings Co overvalued?
Does China Traditional Chinese Medicine Holdings Co pay dividends?
What is China Traditional Chinese Medicine Holdings Co’s EPS estimate?
How many shares outstanding does China Traditional Chinese Medicine Holdings Co have?
What happened to China Traditional Chinese Medicine Holdings Co’s price movement after its last earnings report?
Which hedge fund is a major shareholder of China Traditional Chinese Medicine Holdings Co?
What is the TipRanks Smart Score and how is it calculated?
Company Description
China Traditional Chinese Medicine Holdings Co
China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic of China. The company's product range includes medicinal granules, finished pharmaceutical preparations, pre-portioned decoction materials, and various healthcare products. Furthermore, its operations extend to the cultivation and management of Chinese medicinal herbs, the manufacturing of traditional Chinese medicines, and the trading of pharmaceutical products. It also delivers marketing, advertising, and consulting services related to TCM, and operates retail outlets for pharmaceuticals and decoction products. Property leasing services represent another facet of its business. The company distributes its products to healthcare facilities and retail pharmacies. Established in 1573 and headquartered in Wan Chai, Hong Kong, the firm was formerly known as China Traditional Chinese Medicine Co. Limited before adopting its current name in July 2016.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jun Yang
- Employees
- 14,846
- Website
- www.china-tcm.com.cn
- Address
- HK
China Traditional Chinese Medicine Holdings Co (WSG) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 1 | 5 | 15 |
| Technical Analysis | 1 | 5 | 3 |
| Moving Averages | 0 | 0 | 12 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| HK:0874Guangzhou Baiyunshan Pharmaceutical Holdings Company | ||
| HK:0897Wai Yuen Tong Medicine Holdings Limited | ||
| HK:0512Grand Pharmaceutical Group Limited | ||
| HK:6896Golden Throat Holdings Group Co Ltd | ||
| HK:0719Shandong Xinhua Pharmaceutical Company Limited Class H |
